STREAMEX CORP. Amortization of Debt Issuance Costs
STREAMEX CORP. (STEX) reported Amortization of Debt Issuance Costs of $540.00 thousand for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2025-08-15
- STREAMEX CORP. amortization of debt issuance costs for the quarter ending 2025-06-30 was $540.00K, a 10700.00% increase year-over-year.
- STREAMEX CORP. amortization of debt issuance costs for the quarter ending 2024-06-30 was $5.00K.
- STREAMEX CORP. amortization of debt issuance costs for the quarter ending 2016-09-30 was $0.00.
- STREAMEX CORP. amortization of debt issuance costs for the quarter ending 2015-09-30 was $0.00.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month |
|---|---|---|---|
| 2025-06-30 | $540.00K 10-Q · filed 2025-08-15 | $545.00K 10-Q · filed 2025-08-15 | |
| 2024-06-30 | $5.00K 10-Q · filed 2025-08-15 | $10.00K 10-Q · filed 2025-08-15 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $0.00 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-12 | ||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $585.32K 10-Q · filed 2016-11-14 | |
| 2015-06-30 | $585.32K 10-Q · filed 2016-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B |